Epirubicin Hydrochloride and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Epirubicin Hydrochloride and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: epirubicin
Brand name: Ellence, Pharmorubicin Pfs, Pharmorubicin RDF
Synonyms: Epirubicin, EPIrubicin
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epirubicin Hydrochloride-Insulin degludec
- Epirubicin Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Epirubicin Hydrochloride-Insulin Degludec (U-100) Vials
- Epirubicin Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Epirubicin Hydrochloride-Insulin degludec and liraglutide
- Epirubicin Hydrochloride-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Epirubicin Intravenous, Injection
- Insulin aspart, recombinant Subcutaneous-EPIsnap
- Insulin aspart, recombinant Subcutaneous-Epitol
- Insulin aspart, recombinant Subcutaneous-Epivir
- Insulin aspart, recombinant Subcutaneous-Epivir (Lamivudine Oral Solution)
- Insulin aspart, recombinant Subcutaneous-Epivir (Lamivudine Tablets)